You are here

nDatalyze Corp.

Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
NDAT
CSE Index: 
Currency: 

nDatalyze Corp. generates technology-based, health-related solutions. Investors are encouraged to contact the Corporation by email at jimd@ndatalyze.com or by telephone at (403) 689-3901.

nDatalyze Corp. (NDAT)

(%)

*Financial charts powered by Quotemedia.com. All right reserved. View the Terms of Use. Data delayed 15 minutes unless indicated.

Company Info

Address
1150, 707 - 7 Avenue SW
Calgary, AB T2P 3H6
Canada
Phone
403-689-3901
Email
jimd@ndatalyze.com
Website
https://www.ndatalyze.com
Listing date
Thursday, October 24, 2019
Transfer Agent
Odyssey Trust Company
Auditor
Kenway Mack Slusarchuk Stewart LLP

SEDAR Information

Filing Type Any
Timeframe 1 week1 month3 month6 month1 yearAll Time

Company Info

Address
1150, 707 - 7 Avenue SW
Calgary, AB T2P 3H6
Canada
Phone
403-689-3901
Email
jimd@ndatalyze.com
Website
https://www.ndatalyze.com
Listing date
Thursday, October 24, 2019
Transfer Agent
Odyssey Trust Company
Auditor
Kenway Mack Slusarchuk Stewart LLP

Capitalization

Issued & Outstanding: 
41327425
Reserved for Issuance: 
19847500

Company Officers

James M. Durward, Chief Executive Officer, Chief Technical Officer and Corporate Secretary
Dwayne Vinck, Chief Financial Officer
Dr. Keith Courtney, Chief Psychiatric Officer

News Releases

Bulletins

20/10/2021

2021-1022 – Name and Symbol Change - MedXtractor Corp. (MXT)

le 20 octobre/October 2021

MedXtractor Corp. has announced a name and symbol change to nDatalyze Corp. (NDAT)

Shares will begin trading under the new name, symbol and with a new CUSIP number on October 22, 2021.

Disclosure documents are available at www.thecse.com